In last trading session, Structure Therapeutics Inc ADR (NASDAQ:GPCR) saw 0.72 million shares changing hands with its beta currently measuring -2.85. Company’s recent per share price level of $23.76 trading at $0.37 or 1.60% at ring of the bell on the day assigns it a market valuation of $1.36B. That closing price of GPCR’s stock is at a discount of -164.06% from its 52-week high price of $62.74 and is indicating a premium of 6.02% from its 52-week low price of $22.33.

For Structure Therapeutics Inc ADR (GPCR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.17 in the current quarter.

Structure Therapeutics Inc ADR (NASDAQ:GPCR) trade information

Upright in the green during last session for gaining 1.60%, in the last five days GPCR remained trading in the red while hitting it’s week-highest on Friday, 02/14/25 when the stock touched $23.76 price level, adding 5.6% to its value on the day. Structure Therapeutics Inc ADR’s shares saw a change of -12.37% in year-to-date performance and have moved -2.48% in past 5-day. Structure Therapeutics Inc ADR (NASDAQ:GPCR) showed a performance of -14.94% in past 30-days.

Wall Street analysts have assigned a consensus price target of 105.5 to the stock, which implies a rise of 77.48% to its current value. Analysts have been projecting 93 as a low price target for the stock while placing it at a high target of 118. It follows that stock’s current price would drop -291.41% in reaching the projected high whereas dropping to the targeted low would mean a loss of -291.41% for stock’s current value.

In 2025, company’s earnings growth rate is likely to be around 0.21% while estimates for its earnings growth in next 5 years are of -23.68%.

On the other hand, Smallcap World Fund and Vanguard Specialized-Health Care Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 4.32 shares of worth $102.72 million or 7.55% of the total outstanding shares. The later fund manager was in possession of 4.18 shares on Oct 31, 2024 , making its stake of worth around $99.23 million in the company or a holder of 7.29% of company’s stock.